Rapamycin, Forschungsreagenz

Rapamycin is a macrocyclic triene antibiotic that binds to and inhibits the molecular target of rapamycin (mTOR). Rapamycin is a potent immunosuppressant used as an alternative to calcineurin inhibitors and has anticancer activity. Sirolimus restricts the proliferation of smooth-muscle cells by blocking cell cycle progression at the G1/S transition. Addtional properties: Anti-proliferative, antitumor compound, apoptosis enhancer, anti-HIV, anti-aging. We sell this grade of Rapamycin for R&D use only! Potential mode of action/Key words: mTor inhibitor, Antibiotic, Apoptosis inducer, Antitumoral, Apoptosis enhancers the proliferation of smooth-muscle cells by blocking cell cycle progression at the G1/S transition. Addtional properties: Anti-proliferative, antitumor compound, apoptosis enhancer, anti-HIV, anti-aging. We sell this grade of Rapamycin for R&D useonly! Potential mode of action/Key words: mTor inhibitor, Antibiotic, Apoptosis inducer, Antitumoral, Apoptosis enhancer